导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 15.91% | 555/4773 |
| 近一周 | -4.28% | 5072/5465 |
| 近一月 | 0.10% | 681/5421 |
| 近一季 | 4.91% | 351/5231 |
| 近半年 | -7.39% | 3334/4920 |
| 近一年 | 24.86% | 327/4394 |
| 近两年 | 34.26% | 2125/2954 |
| 近三年 | 28.59% | 1137/2253 |
| 成立以来 | 49.57% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
18.92% 19/4961 |
-16.62% 4738/5312 |
- - |
- - |
| 2025 | 1.77% 3216/4813 |
-9.86% 3439/3635 |
0.46% 2639/4076 |
3.21% 3766/4524 |
8.89% 213/4813 |
| 2024 | 11.33% 1332/3463 |
13.39% 19/2808 |
1.74% 450/3014 |
2.66% 2930/3129 |
-5.99% 2616/3463 |
| 2023 | 13.25% 50/2656 |
7.03% 613/2280 |
-0.91% 427/2385 |
8.47% 16/2515 |
-1.56% 343/2655 |
| 2022 | 11.22% 12/2207 |
13.90% 10/1919 |
7.46% 468/2016 |
4.04% 8/2113 |
-12.65% 2071/2208 |
| 2021 | 36.64% 45/1822 |
5.19% 119/1255 |
13.13% 295/1330 |
32.76% 10/1466 |
-13.52% 1628/1822 |
| 2020 | -5.96% 968/1250 |
-17.89% 999/1028 |
-1.91% 1035/1067 |
6.76% 816/1164 |
9.37% 643/1184 |
| 2019 | 11.79% 724/1092 |
19.84% 617/754 |
-4.28% 425/804 |
-5.29% 790/850 |
2.90% 852/918 |
| 2018 | -25.36% 349/834 |
- - |
- - |
- - |
-19.88% 666/691 |
| 2017 | 9.88% 304/714 |
- - |
- - |
- - |
- - |
| 2016 | -0.24% 106/605 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 广发中证全指能源ETF VS. 长安沪深300非周期A(740101) |